Ду Центр громадського здоровя Міністерства охорони здоровя України
 Скачать 0.7 Mb.
|
|
31(4), 507-513. Boyd, J., Randell, T., Luurila, H., & Kuisma, M. (2003). Serious overdoses involving buprenorphine in Helsinki. Acta Anaesthesiologica Scandinavica, 47(8), 1031-1033. Brahen, L. S., Henderson, R. K., Capone, T., & Kordal, N. (1984). Naltrexone treatment in a jail work-release program. Journal of Clinical Psychiatry, 45(9, Sec. 2), 49-52. Bramness, J. G., Skurtveit, S., Morland, J., & Engeland, A. (2012). An increased risk of motor vehicle accidents after prescription of methadone. Addiction, 107, 967-972. Brown, A. S., & Fleming, P. M. (1998). A naturalistic study of home detoxification from opiates using lofexidine. Journal of Psychopharmacology, 12(1), 93-96. Brown, C. H., Bennett, M. E., Li, L., & Bellack, A. S. (2011). Predictors of initiation and engagement in substance abuse treatment among individuals with co-occurring serious mental illness and substance use disorders. Addictive Behaviors, 36(5), 439-447. Brown, R. T., & Zueldorff, M. (2007). Opioid substitution with methadone and buprenorphine: Sexual dysfunction as a side effect of therapy. Heroin Addiction & Related Clinical Problems, 9(1), 35-44. Bukten, A., Skurtveit, S., Gossop, M., Waal, H., Stangeland, P., Havnes, I., & Clausen, T. (2012). Engagement with opioid maintenance treatment and reductions in crime: a longitudinal national cohort study. Addiction, 107(2), 393-399. Burns, L., Mattick, R. P., Lim, K., & Wallace, C. (2007). Methadone in pregnancy: treatment retention and neonatal outcomes. Addiction, 102(2), 264-270. Burns, L., Randall, D., Hall, W. D., Law, M., Butler, T., Bell, J., & Degenhardt, L. (2009). Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention. Addiction, 104(8), 1363-1372. Cacciola, J. S., & Rutherford, M. (1996). Personality disorders and treatment outcome in methadone maintenance patients. Journal of Nervous and Mental Disease, 184(4), 236-239. Cami, J., Gilabert, M., San, L., & de la Torre, R. (1992). Hypercortisolism after opioid discontinuation in rapid detoxification of heroin addicts. British Journal of Addiction, 87(8), 11451151. Carrieri, M. P., Amass, L., Lucas, G. M., Vlahov, D., Wodak, A., & Woody, G. E. (2006). Buprenorphine use: The international experience. Clinical Infectious Diseases, 43(Suppl 4), S197- S215. Chiang, C. N., & Hawks, R. L. (2003). Pharmacokinetics of the combination tablet of buprenorphine and naloxone. Drug and Alcohol Dependence, 70(Suppl), S39-S47. Chou, R., Hartung, D., Rahman, B., Wasson, N., Cottrell, E. B., & Fu, R. (2013). Comparative effectiveness of antiviral treatment for hepatitis C virus infection in adults: A systematic review. Annals of Internal Medicine, 158, 114-123. Christo, G., & Franey, C. (1995). Drug users’ spiritual beliefs, locus of control and the disease concept in relation to Narcotics Anonymous attendance and six-month outcomes. Drug and Alcohol Dependence, 38, 51-56. Clark, N. C., Lintzeris, N., & Muhleisen, P. J. (2002). Severe opiate withdrawal in a heroin user precipitated by a massive buprenorphine dose. Medical Journal of Australia, 176(4), 166-167. Cleary, B. J., Donnelly, J., Strawbridge, J., Gallagher, P. J., Fahey, T., Clarke, M., & Murphy, D. J. (2010). Methadone dose and neonatal abstinence syndrome - systematic review and metaanalysis. Addiction, 105(12), 2071-2084. Cleary, B. J., Reynolds, K., Eogan, M., O’Connell, M. P., Fahey, T., Gallagher, P. J., ... Murphy, D. J. (2013). Methadone dosing and prescribed medication use in a prospective cohort of opioid-dependent pregnant women. Addiction, 108, 762-770. Cleaver, H., Unell, I., & Aldgate, J. (2011). Children’s Needs-Parenting Capacity (2nd ed.). London, UK: TSO (The Stationery Office). Comer, S. D., Collins, E. D., & Fischman, M. W. (2001). Buprenorphine sublingual tablets: effects on IV heroin self-administration by humans. Psychopharmacology, 154(1), 28-37. Comer, S. D., Sullivan, M. A., Yu, E., Rothenberg, J. L., Kleber, H. D., Kampman, K., ... O’Brien, C. P. (2006). Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial. Archives of General Psychiatry, 63(2), 210-218. Conway, K. P., Compton, W., Stinson, F. S., & Grant, B. F. (2006). Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry, 67(2), 247257. Cook, C. C. H. (1988). The Minnesota Model in the Management of Drug and Alcohol Dependency: miracle, method or myth? Part I. The Philosophy and the Programme. British Journal of Addiction, 83, 625-634. Copeland, J., Gerber, S., & Swift, W. (2006). Evidence-based answers to cannabis questions: a review of the literature. Canberra: Australian National Council on Drugs. Copello, A., Orford, J., Hodgson, R., Tober, G., & Barrett, C. (2002). Social behaviour and network therapy: Basic principles and early experiences. Addictive Behaviors, 27, 345-366. Copello, A., Williamson, E., Orford, J., & Day, E. (2006). Implementing and evaluating Social Behaviour and Network Therapy in drug treatment practice in the UK: A feasibility study. Addictive Behaviors, 31, 802-810. Cornish, R., Macleod, J., Strang, J., Vickerman, P., & Hickman, M. (2010). Risk of death during and after opiate substitution treatment in primary care: Prospective observational study in UK General Practice Research Database. BMJ, 341, с5475. Corsenac, P., Lagarde, E., Gadegbeku, B., Delorme, B., Tricotel, A., Castot, A., ... Orriols, L. (2012). Road traffic crashes and prescribed methadone and buprenorphine: A French registry-based case-control study. Drug and Alcohol Dependence, 123, 91-97. Cousins, G., Teljeur, C., Motterlini, N., McCowan, C., Dimitrov, B. D., & Fahey, T. (2011). Risk of drug-related mortality during periods of transition in methadone maintenance treatment: A cohort study. Journal of Substance Abuse Treatment, 41, 252-260. Coyle, M. G., Salisbury, A. L., Lester, B. M., Jones, H. E., Lin, H., Graf-Rohrmeister, K., & Fischer, G. (2012). Neonatal neurobehavior effects following buprenorphine versus methadone exposure. Addiction, 107(Suppl 1), 63-73. Croop, R. S., Faulkner, E. B., & Labriola, D. F. (1997). The safety profile of naltrexone in the treatment of alcoholism. Archives of General Psychiatry, 54, 1130-1135. Cropsey, K. L., Lane, P. S., Hale, G. J., Jackson, D. O., Clark, C. B., Ingersoll, K. S., ... Stitzer, M. L. (2011). Results of a pilot randomized controlled trial of buprenorphine for opioid dependent women in the criminal justice system. Drug and Alcohol Dependence, 119, 172-178. Cushman, P. (1974). Detoxification of rehabilitated methadone patients: frequency and predictors of long-term success. American Journal of Drug and Alcohol Abuse, 1(3), 393-408. D’Ippoliti, D., Davoli, M., Perucci, C. A., Pasqualini, F., & Bargagli, A. M. (1998). Retention in treatment of heroin users in Italy: the role of treatment type and of methadone maintenance dosage. Drug and Alcohol Dependence, 52, 167-171. Darke, S. (1998). Self-report among injecting drug users: a review. Drug and Alcohol Dependence, 51(3), 253-263. Darke, S., Finlay-Jones, R., Kaye, S., & Blatt, T. (1996). Anti-social personality disorder and response to methadone maintenance treatment. Drug and Alcohol Review, 15, 271-276. Darke, S., McDonald, S., Kaye, S., & Torok, M. (2012). Comparative patterns of cognitive performance amongst opioid maintenance patients, abstinent opioid users and non-opioid users. Drug and Alcohol Dependence, 126(3), 309-315. Darke, S., Mills, K. L., Ross, J., & Teesson, M. (2011). Rates and correlates of mortality amongst heroin users: Findings from the Australian Treatment Outcome Study (ATOS), 2001-2009. Drug and Alcohol Dependence, 115(3), 190-195. Darke, S., Ross, J., Mills, K. L., Williamson, A., Havard, A., & Teesson, M. (2007). Patterns of sustained heroin abstinence amongst long-term, dependent heroin users: 36 months findings from the Australian Treatment Outcome Study (ATOS). Addictive Behaviors, 32(9), 1897-1906. Day, E. (2012). Commentary on Nosyk et al. (2012): Detoxification from methadone maintenance therapy: how important is the exact technique that is used? Addiction, 107, 1630-1631. Day, E., Ison, J., & Strang, J. (2008). Inpatient versus other settings for detoxification for opioid dependence. Cochrane Database of Systematic Reviews(4). doi: 10.1002/14651858.CD004580.pub2 Dean, A. J., Bell, J., Christie, M. J., & Mattick, R. P. (2004). Depressive symptoms during buprenorphine vs. methadone maintenance: findings from a randomised, controlled trial in opioid dependence. European Psychiatry, 19(8), 510-513. Dean, A. J., Saunders, J. B., Jones, R. T., Young, R. M., Connor, J. P., & Lawford, B. R. (2006). Does naltrexone treatment lead to depression? Findings from a randomized controlled trial in subjects with opioid dependence. Journal of Psychiatry and Neuroscience, 31(1), 38-45. Degenhardt, L., Larance, B. K., Bell, J. R., Winstock, A. R., Lintzeris, N., Ali, R. L., Mattick, R. P. (2009). Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulation. MJA, 191, 161-165. Degenhardt, L., Randall, D., Hall, W., Law, M., Butler, T., & Burns, L. (2009). Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved. Drug and Alcohol Dependence, 105(1-2), 9-15. Des Jarlais, D. C., Friedman, S. R., Woods, J., & Milliken, J. (1992). HIV infection among intravenous drug users: Epidemiology and emerging public health perspectives. In J. H. Lowinson, P. Ruiz, R. B. Millman & J. G. Langrod (Eds.), Substance Abuse: A Comprehensive Textbook (2nd ed., pp. 734-743). Baltimore: Williams & Wilkins. DiClemente, C. C., Nidecker, M., & Bellack, A. S. (2008). Motivation and the stages of change among individuals with severe mental illness and substance abuse disorders. Journal of Substance Abuse Treatment, 34(1), 25-35. Doran, C., Holmes, J., Ladewig, D., & Ling, W. (2005). Buprenorphine induction and stabilisation in the treatment of opiate dependence. Heroin Addiction & Related Clinical Problems, 7(1), 7-18. Doris, J. L., Meguid, V., Thomas, M., Blatt, S., & Eckenrode, J. (2006). Prenatal cocaine exposure and child welfare outcomes. Child Maltreatment, 11(4), 326-337. Drummond, D. C. (2001). Theories of drug craving, ancient and modern. Addiction, 96, 3346. Dunlop, A., Petroulias, D., Marope, D., Khoo, K., Kimber, J., Ritter, A., ... Osborn, D. A. (2009). Pharmacotherapies and pregnancy. In R. P. Mattick, R. Ali & N. Lintzeris (Eds.), Pharmacotherapies for Opioid Dependence Treatment (pp. |